NCT01049009 - The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

High Blood Pressure

Interventions

DRUG

Nebivolol

"Subjects will be randomized to either nebivolol or metoprolol xl, and remain on the study drug for 10 weeks. They will then cross over to take 10 weeks of the comparator drug."

DRUG

Metoprolol XL

"Subjects will be randomized to either nebivolol or metoprolol xl, and remain on the study drug for 10 weeks. They will then cross over to take 10 weeks of the comparator drug."

Trial Locations (1)

30322

Emory University, Atlanta